Joint Formulary & PAD

Alteplase - Thrombolysis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
  • Intravenous injection (IV)
Associated Icons :
Restrictions / Comments :

Documentation

PAD Profile

ChemicalSubstance :
Alteplase
Indication :
Thrombolysis
Group Name :
Keywords :
fibrinolytics, thrombolytic therapy, acute ischaemic stroke, acute myocardial infarction, MI, pulmonary embolism, PE
Brand Names Include :
Actilyse
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Alteplase is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Thrombolysis.

Committee Recommendations (1)

NICE guidance discussed at the PCN. Alteplase is not a payment by results excluded drug and should be funded from within tariff by the acute trusts.